Inhaled Ebola vaccine may offer long-term protection from virus

(University of Texas at Austin) A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection against the Ebola virus for non-human primates, as reported this week in Molecular Pharmaceutics. Results from a recent pre-clinical study are first proof a single dose of a non-injectable vaccine platform for Ebola is long lasting. A breathable vaccine could surmount the logistical obstacles of storing, transporting and administering injectable vaccines in ...